Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catheter Precision (VTAK) Cost of Revenue (2017 - 2025)

Historic Cost of Revenue for Catheter Precision (VTAK) over the last 9 years, with Q3 2025 value amounting to $18000.0.

  • Catheter Precision's Cost of Revenue rose 8000.0% to $18000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $54000.0, marking a year-over-year increase of 4210.53%. This contributed to the annual value of $42000.0 for FY2024, which is 4000.0% up from last year.
  • Per Catheter Precision's latest filing, its Cost of Revenue stood at $18000.0 for Q3 2025, which was up 8000.0% from $14000.0 recorded in Q2 2025.
  • In the past 5 years, Catheter Precision's Cost of Revenue ranged from a high of $520000.0 in Q2 2021 and a low of $5000.0 during Q1 2024
  • For the 5-year period, Catheter Precision's Cost of Revenue averaged around $108000.0, with its median value being $14000.0 (2025).
  • In the last 5 years, Catheter Precision's Cost of Revenue crashed by 8947.37% in 2023 and then soared by 12857.14% in 2024.
  • Over the past 5 years, Catheter Precision's Cost of Revenue (Quarter) stood at $347000.0 in 2021, then plummeted by 80.98% to $66000.0 in 2022, then crashed by 89.39% to $7000.0 in 2023, then soared by 57.14% to $11000.0 in 2024, then skyrocketed by 63.64% to $18000.0 in 2025.
  • Its Cost of Revenue stands at $18000.0 for Q3 2025, versus $14000.0 for Q2 2025 and $11000.0 for Q1 2025.